I6A-MC-CBBD - ClinicalTrials.gov - NCT02407054
I6A-MC-CBBD - ClinicalTrials.gov - NCT02407054
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have diagnosis of prostate cancer
Participant must have metastatic disease
Participant must have completed and failed prior abiraterone treatment
Participant must be surgically or medically castrated
Participant must be able to swallow the study drug (pills) whole
Participants must NOT
Participant must not have had prior treatment with chemotherapy or enzalutamide
Participant must not have known brain metastases or uncontrolled hypertension
Participant must not have insulin-dependent diabetes mellitus, however participants with type 2 diabetes mellitus may be eligible
Participant must not have an active, known fungal, bacterial, and/or known viral infection
Trial Summary
Conditions the trial is for
Prostate Cancer
What the trial is testing?
LY3023414 + Enzalutamide, Placebo + Enzalutamide
Could I receive a Placebo?
yes
Enrollment Goal
144
Trial Dates
April 2015 - April 2020
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have diagnosis of prostate cancer
Participant must have metastatic disease
Participant must have completed and failed prior abiraterone treatment
Participant must be surgically or medically castrated
Participant must be able to swallow the study drug (pills) whole
Participants must NOT
Participant must not have had prior treatment with chemotherapy or enzalutamide
Participant must not have known brain metastases or uncontrolled hypertension
Participant must not have insulin-dependent diabetes mellitus, however participants with type 2 diabetes mellitus may be eligible
Participant must not have an active, known fungal, bacterial, and/or known viral infection
Trial Summary
Conditions the trial is for
Prostate Cancer
What the trial is testing?
LY3023414 + Enzalutamide, Placebo + Enzalutamide
Could I receive a Placebo?
yes
Enrollment Goal
144
Trial Dates
April 2015 - April 2020
Trial Phase
2
Trial Locations
Hide locations not currently recruiting